What is she best known for?
The fields of study she is best known for:
- Cancer
- Internal medicine
- Colorectal cancer
Her primary areas of study are Colorectal cancer, Surgery, Total mesorectal excision, Radiation therapy and Cancer.
Her study on Colorectal cancer is covered under Internal medicine.
Her Surgery research incorporates themes from Oxaliplatin and Confidence interval.
She has included themes like Clinical trial, Multicenter trial, Retrospective cohort study, Prospective cohort study and Abdominoperineal resection in her Total mesorectal excision study.
Her work carried out in the field of Radiation therapy brings together such families of science as Neoadjuvant therapy, Randomized controlled trial, Cumulative incidence and Survival rate.
Her Cancer study incorporates themes from Cancer research, Immunology and Pathology.
Her most cited work include:
- Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer (3158 citations)
- Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial (1002 citations)
- ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making (928 citations)
What are the main themes of her work throughout her whole career to date?
Iris D. Nagtegaal mostly deals with Colorectal cancer, Internal medicine, Oncology, Cancer and Pathology.
Her Colorectal cancer study combines topics from a wide range of disciplines, such as Surgery, Radiation therapy, Radiology and Neoadjuvant therapy.
Her research on Surgery often connects related topics like Clinical trial.
In her research on the topic of Internal medicine, Cohort is strongly related with Gastroenterology.
Her research investigates the link between Oncology and topics such as Hazard ratio that cross with problems in Proportional hazards model.
Cancer and Cancer research are commonly linked in her work.
She most often published in these fields:
- Colorectal cancer (54.61%)
- Internal medicine (51.24%)
- Oncology (31.69%)
What were the highlights of her more recent work (between 2019-2021)?
- Internal medicine (51.24%)
- Colorectal cancer (54.61%)
- Oncology (31.69%)
In recent papers she was focusing on the following fields of study:
Her main research concerns Internal medicine, Colorectal cancer, Oncology, Cancer and Gastroenterology.
In the field of Internal medicine, her study on Inflammatory bowel disease, Incidence, Cancer registry and Disease overlaps with subjects such as In patient.
The Colorectal cancer study combines topics in areas such as Neoadjuvant therapy, Surgery and Tumor budding.
The various areas that Iris D. Nagtegaal examines in her Oncology study include Crc screening, Early onset, Tumour budding and MEDLINE.
Her studies deal with areas such as Carcinoma and Family medicine as well as Cancer.
In her study, Cohort study is inextricably linked to Cohort, which falls within the broad field of Gastroenterology.
Between 2019 and 2021, her most popular works were:
- The 2019 WHO classification of tumours of the digestive system. (299 citations)
- Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands. (124 citations)
- Short-course radiotherapy followed by chemotherapy before TME in locally advanced rectal cancer: The randomized RAPIDO trial. (54 citations)
In her most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
Iris D. Nagtegaal mainly investigates Colorectal cancer, Internal medicine, Oncology, Cancer registry and Pathology.
Her studies in Colorectal cancer integrate themes in fields like Neoadjuvant therapy, Pathological, Feces, Radiology and Disease.
In her study, which falls under the umbrella issue of Internal medicine, Confidence interval, Cohort and Stage is strongly linked to Gastroenterology.
Her Oncology study integrates concerns from other disciplines, such as Stage III Colon Cancer, Tumour budding, Genetic testing and Genetic predisposition.
Her research investigates the connection with Cancer registry and areas like Retrospective cohort study which intersect with concerns in Primary tumor, Surgical oncology, Metastasectomy, Relative survival and Rectum.
Her Pathology research includes themes of Gold standard, Molecular phenotype and Cystadenoma.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
